Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Comparison of the clinical and imaging data between the two groups

From: Prediction of peripheral lymph node metastasis (LNM) in thyroid cancer using delta radiomics derived from enhanced CT combined with multiple machine learning algorithms

Factors

LNM group (N = 88)

non-LNM group (N = 287)

X2, Z or t value

P

Sex

  

3.98

0.04*

 Male

49

125

  

 Female

39

162

  

Hashimoto's thyroiditis

  

4.87

0.03*

 No

67

247

  

 Yes

21

40

  

Microcalcifications

  

0.29

0.58

 No

64

217

  

 Yes

24

70

  

Tumour aspect ratio

  

1.56

0.21

 1 (< 1)

63

224

  

 2 (> 1)

25

63

  

Tumour location

  

1.39

0.16

 1 (Upper lobe)

38

144

  

 2 (Middle lobe)

17

58

  

 3 (Inferior lobe)

33

85

  

Tumour adjacency to the thyroid capsule

  

3.33

 < 0.05*

 1 (away from the capsule)

44

203

  

 2 (closely adherent to the capsule)

32

61

  

 3 (penetrated the capsule)

12

23

  

Pathological subtype

  

4.72

 < 0.05*

 3 (papillary carcinoma)

41

199

  

 2 (follicular carcinoma)

32

75

  

 1 (medullary and anaplastic carcinoma)

15

13

  

Grading of tumour ultrasound elastography

  

1.75

0.08

 1

42

165

  

 2

17

61

  

 3

21

36

  

 4

4

16

  

 5

4

9

  

Hypertension history

8.73 ± 7.26

13.31(0,11.13)

0.47

0.63

Diabetes history

3.31(0,6.23)

3.00(0,7.01)

0.52

0.61

Smoking history

8.78 ± 7.21

8.13 ± 6.89

0.76

0.45

Drinking history

9.98 ± 8.92

8.66 ± 8.77

1.23

0.22

Tumour diameter

11.37 ± 1.56

11.21 ± 1.64

0.84

0.39

BMI

22.70 ± 2.61

22.45 ± 2.62

0.79

0.42

Triiodothyronine (T3) level

1.26 ± 0.31

1.32 ± 0.35

1.49

0.14

Thyroxine(T4) level

9.38 ± 2.78

9.64 ± 2.91

0.75

0.45

Thyroid-stimulating hormone (TSH) level

3.75 ± 1.57

3.90 ± 1.68

0.73

0.46

Plain CT value

50.03 ± 10.16

54.90 ± 12.55

1.27

0.21

Arterial phase CT value

108.44 ± 20.67

103.60(86.70,114.31)

1.77

0.08

Venous phase CT value

102.63 ± 19.92

103.60(83.70,112.40)

1.81

0.07

Age

46.51 ± 7.62

46.04 ± 6.58

0.56

0.57

Delta Radscore

0.32 ± 0.08

0.21 ± 0.09

9.62

 < 0.05*

Radscore 1

0.32 ± 0.09

0.21 ± 0.11

8.53

 < 0.05*

  1. *P < 0.05 indicates a statistically significant difference